搜尋結果
These Android Apps Are Dangerous Fakes—Check Your Phone Now
Forbes· 2 日前Just as Apple opens its iPhone to third-party app stores and direct downloads, here comes ...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 7 日前Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on ...
This $2.2 Billion Startup’s GPT-4 Powered AI Bot Demystifies Health Insurance
Forbes· 22 小時前Glen Tullman believes telehealth, as we know it, is dead. The future, according to the venture ...
Council Post: Trade Shows Are Still An Invaluable Marketing Tool
Forbes· 22 小時前Tony Ambroza is Chief Growth Officer at RealTruck, an omni-channel industry leader in truck and ...
13. Notion
CNBC· 2 日前There is no shortage of work productivity and management tools available today, but few have the enthusiastic user base ...
Why build a tech mafia when you can just build each other?
TechCrunch· 4 日前Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the ...
TikTok Without ByteDance Is Like Bill Belichick Without Tom Brady
Forbes· 2 日前The assumption behind the hiring is that assistants will bring with them the winning ways of ...
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal· 2 日前, one of the world’s largest makers of generic drugs, has been in the penalty box with ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 6 日前, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months ...
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 6 日前, opens new tab to market its blockbuster obesity treatment drugs in India, the company's ...